tiprankstipranks
Trending News
More News >
Syros Pharmaceuticals (SYRS)
:SYRS
US Market

Syros Pharmaceuticals (SYRS) Stock Forecast & Price Target

Compare
1,078 Followers
See the Price Targets and Ratings of:

SYRS Financial Forecast

SYRS Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

SYRS Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen
Hold
Assigned
11/13/24
Syros Pharmaceuticals (SYRS) was downgraded to a Hold Rating at TD Cowen
Brookline Capital Markets
Hold
Downgraded
11/12/24
Syros Pharmaceuticals downgraded to Hold from Buy at BrooklineSyros Pharmaceuticals downgraded to Hold from Buy at Brookline
Piper Sandler
$5
Buy
12400.00%
Upside
Reiterated
10/23/24
Piper Sandler Remains a Buy on Syros Pharmaceuticals (SYRS)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen
Hold
Assigned
11/13/24
Syros Pharmaceuticals (SYRS) was downgraded to a Hold Rating at TD Cowen
Brookline Capital Markets
Hold
Downgraded
11/12/24
Syros Pharmaceuticals downgraded to Hold from Buy at BrooklineSyros Pharmaceuticals downgraded to Hold from Buy at Brookline
Piper Sandler
$5
Buy
12400.00%
Upside
Reiterated
10/23/24
Piper Sandler Remains a Buy on Syros Pharmaceuticals (SYRS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Syros Pharmaceuticals

Which Analyst Should I Follow If I Want to Buy SYRS and Sell After:
1 Month
xxx
Success Rate
8/12 ratings generated profit
67%
Average Return
+0.63%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +0.63% per trade.
3 Months
xxx
Success Rate
4/12 ratings generated profit
33%
Average Return
-4.76%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -4.76% per trade.
1 Year
Edward TenthoffPiper Sandler
Not Ranked
Success Rate
2/12 ratings generated profit
17%
Average Return
-57.38%
reiterated a buy rating 6 months ago
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -57.38% per trade.
2 Years
xxx
Success Rate
0/12 ratings generated profit
0%
Average Return
-93.53%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -93.53% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SYRS Analyst Recommendation Trends

Rating
Aug 24
Oct 24
Nov 24
Dec 24
Feb 25
Strong Buy
8
7
7
3
1
Buy
3
3
2
1
0
Hold
0
0
4
5
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
10
13
9
7
In the current month, SYRS has received 1 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. SYRS average Analyst price target in the past 3 months is 1.00.
Each month's total comprises the sum of three months' worth of ratings.

SYRS Stock Forecast FAQ

What is SYRS’s average 12-month price target, according to analysts?
Based on analyst ratings, Syros Pharmaceuticals’s 12-month average price target is 1.00.
    What is SYRS’s upside potential, based on the analysts’ average price target?
    Syros Pharmaceuticals has 2400.00% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SYRS a Buy, Sell or Hold?
          Syros Pharmaceuticals has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Syros Pharmaceuticals’s price target?
            The average price target for Syros Pharmaceuticals is 1.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $1.00 ,the lowest forecast is $1.00. The average price target represents 2400.00% Increase from the current price of <$0.1.
              What do analysts say about Syros Pharmaceuticals?
              Syros Pharmaceuticals’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of SYRS?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis